Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic Garners Bilateral Activa Medicare Reimbursement In 33 States

This article was originally published in The Gray Sheet

Executive Summary

Medtronic Neurological President Scott Ward acknowledges that current off-label use of the company's Activa deep brain stimulation device for the bilateral treatment of Parkinson's tremor may dampen sales expectations once FDA approves the indication.

You may also be interested in...



CMS Reviewing Medtronic Activa Reimbursement For Bilateral Indication

The Centers for Medicare & Medicaid Services has initiated a national coverage review of Medtronic's Activa for bilateral brain stimulation in Parkinson's disease patients, but the agency will not reimburse the indication until it is approved by FDA.

CMS Reviewing Medtronic Activa Reimbursement For Bilateral Indication

The Centers for Medicare & Medicaid Services has initiated a national coverage review of Medtronic's Activa for bilateral brain stimulation in Parkinson's disease patients, but the agency will not reimburse the indication until it is approved by FDA.

Medtronic Holding Pat On $480 Mil. Acquisition Offer Spurned By Cyberonics

Medtronic's stalled $480 mil. acquisition bid for Cyberonics may be the first test for President and Chief Operating Officer Arthur Collins as he prepares to assume the top executive post at Medtronic next spring.

UsernamePublicRestriction

Register

LL1134478

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel